Clinical Trial Update: Immunogenicity and Safety of Enterovirus Type 71 Vaccine,Inactivated(Vero Cells) in Volunteers Aged From 6 to 71 Months [Phase 2]

View source ↗

Summary

Phase 2 trial results reporting immunogenicity and safety of an inactivated Enterovirus Type 71 vaccine (Vero cell–based) in volunteers aged 6 to 71 months; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterovirus Type 71 Disease
• Hand Foot and Mouth Disease

Drugs mentioned

• Enterovirus Type 71 Vaccine, Inactivated (Vero Cells) (Enterovirus Type 71 vaccine, inactivated (Vero cell–based))

Snippet

Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Conditions: Healthy Volunteers | Phase 2 | Status: COMPLETED